Review of Active Extracorporeal Medical Devices to Counteract Freezing of Gait in Patients with Parkinson Disease.

Healthcare (Basel)

GRID Research Group, Universidad Internacional de Valencia, 46002 Valencia, Spain.

Published: May 2022

Parkinson Disease (PD) primarily affects older adults. It is the second-most common neurodegenerative disease after Alzheimer's disease. Currently, more than 10 million people suffer from PD, and this number is expected to grow, considering the increasing global longevity. Freezing of Gait (FoG) is a symptom present in approximately 80% of advanced-stage PD's patients. FoG episodes alter the continuity of gait, and may be the cause of falls that can lead to injuries and even death. The recent advances in the development of hardware and software systems for the monitoring, stimulus, or rehabilitation of patients with FoG has been of great interest to researchers because detection and minimization of the duration of FoG events is an important factor in improving the quality of life. This article presents a review of the research on non-invasive medical devices for FoG, focusing on the acquisition, processing, and stimulation approaches used.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222598PMC
http://dx.doi.org/10.3390/healthcare10060976DOI Listing

Publication Analysis

Top Keywords

medical devices
8
freezing gait
8
parkinson disease
8
patients fog
8
fog
5
review active
4
active extracorporeal
4
extracorporeal medical
4
devices counteract
4
counteract freezing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!